News

CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a ...
Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...
The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...
The clinical-stage biotech company is based in Sacramento, and is putting its drug candidate through medical trials.
More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...
The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.
Vinay Prasad, a skeptic of mainstream medicine, is now a top FDA official. Change is coming for some drugmakers, one way or ...
Elizabeth Holmes is still locked up in prison for defrauding investors who believed in her biotech startup company, Theranos.
Find out the best way to find the right CDMO for your biotech. Experts shared some advice to help companies through the ...
Amid a shaky macroeconomic backdrop, biotech stocks have underperformed, with XBI showing poor technical momentum and ...
Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...